Efficacy of acupuncture for chronic migraine: a protocol for a multicenter randomized controlled trial
Abstract
Introduction Chronic migraine (CM) is a prevalent neurovascular disorder that significantly affects quality of life. Research has shown promising results for the efficacy of acupuncture in the treatment of chronic migraine. This study aims to evaluate the efficacy of acupuncture as a prophylactic treatment for chronic migraine through a multicenter randomized controlled trial. Materials and methods This investigation constitutes a prospective, two-arm, multicenter randomized controlled trial involving a total of 180 patients diagnosed with chronic migraine (CM). Participants will be allocated in a 2:1 ratio to either the treatment group, receiving acupuncture, or the control group, receiving sham acupuncture. The intervention will be administered three times per week over a 6-week treatment period, followed by an 8-week follow-up phase. The primary outcome measure is the change from baseline in the average number of monthly headache days during weeks 3–6 of the treatment period. Secondary outcomes include changes in monthly headache days during follow-up, acute medication use days (AMDs), Migraine-Specific Quality of Life (MSQ), headache symptom scores, and pain severity as assessed using the visual analog scale (VAS). Ethics and dissemination The study was approved by the Ethics Committee of Shandong University of Traditional Chinese Medicine (approval number: 2024-014-01-KY) and is registered with the Chinese Clinical Trial Registry (registration number: ChiCTR2400084720).…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 180 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.